⌘K

Login Start Free

Home/Filings/4/0001493152-24-048756

4//SEC Filing

Lacey John III 4

Accession 0001493152-24-048756

CIK 0000315545other

View on SEC.gov Company Profile

Filed

Dec 3, 7:00 PM ET

Accepted

Dec 4, 9:49 PM ET

Size

5.6 KB

Accession

0001493152-24-048756

Insider Transaction Report

Form 4

Period: 2024-12-02

PROVECTUS BIOPHARMACEUTICALS, INC.PVCT

Director

Transactions

Award
Stock Options (Right to Buy)
2024-12-02+775,082→ 775,082 total
Exercise: $0.29From: 2024-12-02Exp: 2034-12-02→ Common Stock (775,082 underlying)

Documents

1 file

4
ownership.xmlPrimary

Issuer

PROVECTUS BIOPHARMACEUTICALS, INC.

CIK 0000315545

Entity typeother

Related Parties

1

filerCIK 0001739761

Filing Metadata

Form type: 4
Filed: Dec 3, 7:00 PM ET
Accepted: Dec 4, 9:49 PM ET
Size: 5.6 KB

View on SEC.gov